GSTM1 and tuberculosis: The proportion of the GSTM1-null genotype in our Caucasian cohort was 59%; however, we did not observe any effects of GSTM1 genotype on DIH, TB treatment outcome, or any of the six INH pharmacokinetic parameters studied.